News & Filings
ONESOURCE \u2014 Recent Activity
2 items in the last 14 days
AI Summary
OneSource Specialty Pharma Ltd recently reported its Q3 2026 earnings, which may impact its stock price and investor returns. The company's financial performance could influence the overall pharmaceutical sector and the broader Indian stock market. Investors should stay informed about the company's progress and the market's reaction to its earnings reports to make informed decisions about their investments.
OneSource Specialty Pharma Ltd (BOM:544292) Q3 2026 Earnings Call Highlights: Navigating ...
Despite regulatory delays impacting revenue, OneSource Specialty Pharma Ltd (BOM:544292) remains optimistic about future growth with strategic capacity expansions and strong market demand.
Click to open →
OneSource Specialty Pharma Ltd (BOM:544292) Q2 2026 Earnings Call Highlights: Robust Growth ...
OneSource Specialty Pharma Ltd (BOM:544292) reports strong EBITDA growth and a surge in biologics, while navigating capacity and regulatory hurdles.
Click to open →
Get alerts for important filings
Add ONESOURCE to your watchlist for board meeting & dividend alerts.
Open analysis →News from yfinance + BSE corporate announcements. Importance scoring is automated. YieldIQ is not registered with SEBI as an investment adviser.